{"disease":{"id":"oligometastasis","name":"oligometastasis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05352178","title":"Metastasis-directed Therapy for Oligorecurrent Prostate Cancer","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":873,"lead_sponsor_name":"Universitaire Ziekenhuizen KU Leuven","has_results":false},{"nct_id":"NCT06563388","title":"Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"Roswell Park Cancer Institute","has_results":false},{"nct_id":"NCT06430411","title":"Outcomes of Local Treatment for Oligometastatic Prostate Cancer Diagnosed Using PSMA PET Imaging: OLIGOMET Study","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":500,"lead_sponsor_name":"Medical University of Vienna","has_results":false},{"nct_id":"NCT04172753","title":"Feasibility of Online MR-guided Radiotherapy on a 1.5T MR-Linac","phase":"NA","overall_status":"RECRUITING","enrollment_count":472,"lead_sponsor_name":"University Hospital Tuebingen","has_results":false},{"nct_id":"NCT06644430","title":"Ablation of Pulmonary Oligometastasis Combined With System for Advanced Hepatocellular Carcinoma","phase":"","overall_status":"RECRUITING","enrollment_count":470,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT04787744","title":"Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":464,"lead_sponsor_name":"VA Office of Research and Development","has_results":false},{"nct_id":"NCT06135714","title":"Metastasis-directed Therapy for Oligometastases of Breast Cancer","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":340,"lead_sponsor_name":"Tokyo Medical and Dental University","has_results":false},{"nct_id":"NCT07397585","title":"stereOtactic Body RadIothErapy for exTracranial oligomeTastAtic Breast Cancer: Multi Institutional Retrospective Database","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Istituto Clinico Humanitas","has_results":false},{"nct_id":"NCT04498767","title":"Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)","phase":"NA","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"European Organisation for Research and Treatment of Cancer - EORTC","has_results":false},{"nct_id":"NCT04158843","title":"Radical Local vs. Palliative Therapy for Breast Cancer Patientts With Ipsilateral Humerus or Sternum Oligometastasis","phase":"NA","overall_status":"RECRUITING","enrollment_count":183,"lead_sponsor_name":"xuexin he","has_results":false},{"nct_id":"NCT04641078","title":"Stereotactic Body Radiotherapy With or Without Darolutamide for OligoRecurrent Prostate Cancer","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":124,"lead_sponsor_name":"University Hospital, Ghent","has_results":false},{"nct_id":"NCT03161522","title":"Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT07121335","title":"SMC Radiation Oncology SABR Cohort for Oligometastasis","phase":"","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Samsung Medical Center","has_results":false},{"nct_id":"NCT06550921","title":"Ablation of Oligometastasis Combined With Lenvatinib and PD-1 Inhibitor for Advanced Hepatocellular Carcinoma","phase":"NA","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT04221516","title":"Camrelizumab After Completion of Radiotherapy for Oligometastatic Nasopharyngeal Carcinoma","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":52,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT04486287","title":"Sintilimab After Stereotactic Ablation Brachytherapy for Refractory Oligometastatic Non-Small Cell Lung Cancer","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":44,"lead_sponsor_name":"Tianjin Medical University Second Hospital","has_results":false},{"nct_id":"NCT05173610","title":"Stereotactic Ablative Radiotherapy for Oligometastatic Hepatocellular Carcinoma","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Yonsei University","has_results":false},{"nct_id":"NCT05055583","title":"Toripalimab in Combination With Platinum-based Chemotherapy for Mutation-negative Stage IV Oligometastatic NSCLC","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Tang-Du Hospital","has_results":false},{"nct_id":"NCT03796767","title":"Salvage Oligometastasectomy and Radiation Therapy in Recurrent Prostate Cancer","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":20,"lead_sponsor_name":"University of Utah","has_results":true}],"total":19},"guidelines":[],"source":"Drug Landscape verified database"}